Eliana Clark

Eliana Clark, PhD is the Senior Vice President of Technical Operations at Intellia Therapeutics, where she is responsible for Process and Analytical Development, Internal and External Manufacturing, Supply Chain, and CMC Strategy and Operations for novel gene editing-based products, both ex-vivo cell-based therapies and in vivo therapies. Dr. Clark joined Intellia in January of 2020. Prior to Intellia, Dr. Clark was at Biogen for nearly eight years. In her most recent role at Biogen, she led the team responsible for the CMC product strategy and lifecycle management for Biogen’s product portfolio including clinical and commercial products. Prior to that, Dr. Clark was responsible for Biogen’s International Manufacturing Operations, managing a large biologics manufacturing plant in Denmark, a biologics manufacturing facility construction and start-up in Switzerland, and Biogen’s worldwide CMO network. Prior to leading International Manufacturing Operations, Dr. Clark was responsible for Biogen’s Global Manufacturing Sciences, the technical team supporting all worldwide manufacturing operations. Prior to Biogen, Dr. Clark was at Sanofi Genzyme for eleven years where she held leadership roles in CMC Regulatory, Manufacturing Sciences and Technology Development. Prior to working in industry, Dr. Clark was a professor of Chemical and Biological Engineering at Tufts University.